Levocetirizine Dihydrochloride Brillpharma (Ireland)

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Dihydrochloride Brillpharma, is an antihistamine presented as an oral dosage form for oral use. It is employed to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children where appropriate. GNH USA supplies Levocetirizine Dihydrochloride Brillpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Dihydrochloride acts on the histamine H1 receptor pathway to control allergic conditions. - Allergic rhinitis: reduces nasal congestion, sneezing and itching. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or outdoor allergens. - Chronic idiopathic urticaria: diminishes wheal formation and pruritus associated with chronic hives.

Levocetirizine Dihydrochloride is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild sedation may be experienced. - Headache: transient headache reported by some patients. - Dry mouth: reduced salivation leading to a dry oral cavity. - Fatigue: a feeling of tiredness without exertion.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, or tongue requiring immediate attention. - Severe skin rash: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic reaction: rare systemic allergic response that can be life‑threatening.

Before initiating therapy, consider the following precautions. - Pregnancy: consult a healthcare professional to weigh potential benefits against risks. - Breastfeeding: assess the need for treatment and possible infant exposure. - Renal impairment: dose adjustment may be necessary in patients with reduced kidney function. - Elderly patients: monitor for increased sedation or dizziness. - Concomitant CNS depressants: may potentiate drowsiness and should be used with caution. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Levocetirizine Dihydrochloride can interact with several drug classes.

Major Interactions (Avoid): - Alcohol: may enhance sedative effects. - Other antihistamines: additive antihistaminic activity can increase side‑effects. - Strong CYP3A4 inhibitors: may raise plasma concentrations of levocetirizine.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): monitor for excessive drowsiness. - Theophylline: levocetirizine may increase theophylline levels, requiring observation.